I expect the vendor would have wanted a much reduced script price to that originally agreed given the recent trading range. The best take on it all is that SRY weren't willing to offer script at too low a price with the view that the company is currently materially undervalued.
Would be nice if they gave a bit more detail or at least provided some more colour on how the company is going more generally.
Not a great loss - i think they should keep their focus on Indonesia in any event and build scale there.
- Forums
- ASX - By Stock
- SRY
- Ann: Termination of acquisition of MyMac
Ann: Termination of acquisition of MyMac, page-3
Featured News
Add SRY (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.505M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
SRY (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online